TSCAN THERAPEUTICS INC (TCRX:NASDAQ)
$1.05 -0.01 (-0.9434%)
Analysed TSCAN THERAPEUTICS INC (TCRX:NASDAQ) News Sources
TScan Therapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference
08-04-2026
yahoo.com
Strong Analyst Sentiment on TScan Therapeutics (TCRX) Amid Ongoing Momentum in Cell Therapy Space
25-03-2026
yahoo.com
TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Misses Revenue Estimates
04-03-2026
yahoo.com
TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
04-03-2026
yahoo.com
TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03
26-02-2026
yahoo.com
Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Beats Revenue Estimates
25-02-2026
yahoo.com
TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
25-02-2026
yahoo.com
Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Beats Revenue Estimates
12-02-2026
yahoo.com
Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains?
11-02-2026
yahoo.com
Roivant Sciences Ltd. (ROIV) Reports Q3 Loss, Misses Revenue Estimates
06-02-2026
yahoo.com
What is the current price of TSCAN THERAPEUTICS INC (TCRX:NASDAQ)?
The current price of TSCAN THERAPEUTICS INC (TCRX:NASDAQ) is $1.05.
TSCAN THERAPEUTICS INC (TCRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of TSCAN THERAPEUTICS INC (TCRX:NASDAQ) since the previous trading day is $-0.01.
TSCAN THERAPEUTICS INC (TCRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of TSCAN THERAPEUTICS INC (TCRX:NASDAQ) since the previous trading day is -0.9434%.
What is the most recent average sentiment score for TSCAN THERAPEUTICS INC (TCRX:NASDAQ)?
The most recent average sentiment score for TSCAN THERAPEUTICS INC (TCRX:NASDAQ) is 59 out of 100.
What is the most recent average sentiment for TSCAN THERAPEUTICS INC (TCRX:NASDAQ)?
The most recent sentiment for TSCAN THERAPEUTICS INC (TCRX:NASDAQ) is .
SEC-8K** Filing Available For TSCAN THERAPEUTICS INC (TCRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.